Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2017

Feb 12, 2018

SELL
$81.94 - $87.89 $275,318 - $295,310
-3,360 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$77.07 - $85.54 $258,955 - $287,414
3,360
3,360 $287,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $743B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track East Coast Asset Management, Llc. Portfolio

Follow East Coast Asset Management, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of East Coast Asset Management, Llc., based on Form 13F filings with the SEC.

News

Stay updated on East Coast Asset Management, Llc. with notifications on news.